Literature DB >> 7606890

Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens.

V Dolo1, E Adobati, S Canevari, M A Picone, M L Vittorelli.   

Abstract

We have compared the pattern of surface antigen expression, as detected by monoclonal antibodies (mAbs), in plasma membranes vs shed membrane vesicles of two human breast carcinoma cell lines, MCF-7 and 8701-BC. Antigen expression was detected on cells by immunofluorescence (IF) analysis, whilst, due to their small dimensions, the same technique was not applicable to vesicles. For these structures dot-blot analysis and immunoelectron microscopy (IEM) were employed. When applicable, both cell membranes and membrane vesicles were immunoprecipitated and the precipitate (IP) was analyzed by SDS-PAGE. Cells of both lines expressed HLA class I antigens, epithelial cytokeratins, beta 1 integrins, CEA and the glycoprotein detected by mAb 19.9, but only MCF-7 cells expressed Lewis Y, episialin and globo-H antigens and only 8701-BC cells expressed folate receptor. Membrane vesicles of both cell lines appeared to be rich in beta 1, alpha 3 and alpha 5 integrin chains, expressed HLA class I antigens and carried most of the plasma membrane antigens found in the cell membranes. Overall we have analyzed 17 antigens on the two cell lines and on their vesicles. The results obtained for cells (IF and IP) and those for vesicles (dot-blot and IP) were generally concordantly positive or concordantly negative. We obtained a total of 26 clearly concordant combinations on 34 analyses. In three cases we found discordant results, whereas in the remaining combinations we observed slight reactivity and we found difficulties in determining concordance. Discordant results concerned the expression of the following antigens: folate receptors, which were clearly expressed in 8701-BC cells but not detected by dot-blot analysis or IEM on their shed membrane vesicles; neu (c-erb-B2) receptor found in MCF-7 cell membranes but not in their vesicles; and the globo-H antigen recognized by mAb MBr1, detected at low levels on 8701-BC plasma membranes but undetectable on their membrane vesicles. Like vesicles shed in vitro by cultured cells, the vesicles shed in vivo by human breast carcinoma cells could be tagged with several antibodies against tumor-associated antigens. The vesicles shed in vivo were found in association with a fiber network. Some of the fibers had the characteristic fibrin periodicity. These data suggest that tumor markers detected in the circulation of carcinoma patients, at least in part, are carried by shed membrane vesicles. Moreover the observation that membrane vesicles carry both tumor-associated antigens and HLA class I molecules indicate that these structures could in principle present antigens to the immune system.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7606890     DOI: 10.1007/BF00133483

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  30 in total

Review 1.  Shedding of plasma membrane fragments. Neoplastic and developmental importance.

Authors:  D D Taylor; P H Black
Journal:  Dev Biol (N Y 1985)       Date:  1986

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Tumor shedding and coagulation.

Authors:  H F Dvorak; S C Quay; N S Orenstein; A M Dvorak; P Hahn; A M Bitzer; A C Carvalho
Journal:  Science       Date:  1981-05-22       Impact factor: 47.728

4.  Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities.

Authors:  V Dolo; A Ginestra; G Ghersi; H Nagase; M L Vittorelli
Journal:  J Submicrosc Cytol Pathol       Date:  1994-04

5.  Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction.

Authors:  E van de Wiel-van Kemenade; M J Ligtenberg; A J de Boer; F Buijs; H L Vos; C J Melief; J Hilkens; C G Figdor
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

6.  Characterization of cellular and extracellular plasma membrane vesicles from a non-metastasizing lymphoma (Eb) and its metastasizing variant (ESb).

Authors:  D Barz; M Goppelt; M Szamel; V Schirrmacher; K Resch
Journal:  Biochim Biophys Acta       Date:  1985-03-28

7.  Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells.

Authors:  G Poste; G L Nicolson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

Review 8.  Transfected MCF-7 cells as a model for breast-cancer progression.

Authors:  F G Kern; S W McLeskey; L Zhang; J Kurebayashi; Y Liu; I Y Ding; S Kharbanda; D Chen; D Miller; K Cullen
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.

Authors:  S Miotti; S Canevari; S Ménard; D Mezzanzanica; G Porro; S M Pupa; M Regazzoni; E Tagliabue; M I Colnaghi
Journal:  Int J Cancer       Date:  1987-03-15       Impact factor: 7.396

10.  A new cell line (8701-BC) from primary ductal infiltrating carcinoma of human breast.

Authors:  S Minafra; V Morello; F Glorioso; A M La Fiura; R M Tomasino; S Feo; D McIntosh; D E Woolley
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

View more
  17 in total

1.  Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells.

Authors:  Giulia Taraboletti; Sandra D'Ascenzo; Patrizia Borsotti; Raffaella Giavazzi; Antonio Pavan; Vincenza Dolo
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

2.  Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines.

Authors:  A Angelucci; S D'Ascenzo; C Festuccia; G L Gravina; M Bologna; V Dolo; A Pavan
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 3.  Exosomes Derived from Breast Cancer Cells, Small Trojan Horses?

Authors:  Alejandro Villagrasa; Pablo Juan Álvarez; Antonio Osuna; Jose Manuel Garrido; Antonia Aránega; Fernando Rodríguez-Serrano
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-07-01       Impact factor: 2.673

4.  Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro.

Authors:  V Dolo; S D'Ascenzo; S Violini; L Pompucci; C Festuccia; A Ginestra; M L Vittorelli; S Canevari; A Pavan
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

5.  An active form of sphingosine kinase-1 is released in the extracellular medium as component of membrane vesicles shed by two human tumor cell lines.

Authors:  Salvatrice Rigogliuso; Chiara Donati; Donata Cassarà; Simona Taverna; Monica Salamone; Paola Bruni; Maria Letizia Vittorelli
Journal:  J Oncol       Date:  2010-05-24       Impact factor: 4.375

6.  Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles.

Authors:  Ilaria Giusti; Sandra D'Ascenzo; Danilo Millimaggi; Giulia Taraboletti; Gaspare Carta; Nicola Franceschini; Antonio Pavan; Vincenza Dolo
Journal:  Neoplasia       Date:  2008-05       Impact factor: 5.715

7.  Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells.

Authors:  Danilo Millimaggi; Marianna Mari; Sandra D'Ascenzo; Eleonora Carosa; Emmanuele Angelo Jannini; Stanley Zucker; Gaspare Carta; Antonio Pavan; Vincenza Dolo
Journal:  Neoplasia       Date:  2007-04       Impact factor: 5.715

8.  EGFR mediates LPA-induced proteolytic enzyme expression and ovarian cancer invasion: inhibition by resveratrol.

Authors:  Kang Jin Jeong; Kyung Hwa Cho; Nattapon Panupinthu; Hoon Kim; Jaeku Kang; Chang Gyo Park; Gordon B Mills; Hoi Young Lee
Journal:  Mol Oncol       Date:  2012-10-23       Impact factor: 6.603

Review 9.  A Molecular View of Pathological Microcalcification in Breast Cancer.

Authors:  Tanu Sharma; James A Radosevich; Geeta Pachori; Chandi C Mandal
Journal:  J Mammary Gland Biol Neoplasia       Date:  2016-01-15       Impact factor: 2.673

10.  CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells.

Authors:  Ching-Fong Liao; Shu-Hui Lin; Hung-Chang Chen; Cheng-Jeng Tai; Chun-Chao Chang; Li-Tzu Li; Chung-Min Yeh; Kun-Tu Yeh; Ying-Chun Chen; Tsu-Han Hsu; Shing-Chuan Shen; Woan-Ruoh Lee; Jeng-Fong Chiou; Shue-Fen Luo; Ming-Chung Jiang
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.